Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…
Content:; Melanoma / Ali Al-Haseni and Debjani Sahni -- Squamous cell carcinoma / Ali Al-Haseni and Debjani Sahni -- Basal cell carcinoma / Ali Al-Haseni and Debjani Sahni -- Cutaneous lymphoma / Bilal Fawaz and Debjani Sahni -- Kaposi's sarcoma / Bilal Fawaz and Debjani Sahni -- Dermatofibrosarcom…